Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fermenta Biotech will hold an in-person investor/analyst meet on June 15, 2026, in Mumbai. The discussions will cover the audited financial results for the year ended March 31, 2026, and the investor presentation, with no unpublished price sensitive information to be shared.
Jun 09 2026 17:08:03
Fermenta Biotech Ltd - 506414 - Corporate Action-Board approves Dividend
Fermenta Biotech board recommended a final dividend of ₹3.75 per share (75% on ₹5 face value) for FY26. Payment by August 21, 2026, pending shareholder approval.
May 26 2026 17:04:49
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fermenta Biotech announced its audited FY26 consolidated financial results, with revenue growing 14% YoY to Rs.547.8 crore. The company saw strong operational leverage, with EBITDA (excluding real estate) rising 44% to Rs.120 crore, confirming the FY25 turnaround.
May 26 2026 16:48:47
Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026 And Consideration Of Final Equity Dividend, If Any.
Fermenta Biotech's Board of Directors will hold a meeting on May 26, 2026. The agenda includes the consideration and approval of the audited financial results for the fourth quarter and full financial year ended March 31, 2026, and a final equity dividend for FY26.
May 19 2026 18:46:57
Read More